Af­ter a busy year of build­outs, Ther­mo Fish­er sets plans for growth in 2023

Last year, Ther­mo Fish­er ex­pand­ed wide­ly across the US and abroad. This year, how­ev­er, it’s ex­pect­ing a big dip in vac­cine and ther­a­peu­tics rev­enue.

The com­pa­ny brought in $44.92 bil­lion in rev­enue last year, a growth of 15%, with rev­enues in the fourth quar­ter to­tal­ing $11.45 bil­lion, a 7% growth from 2021. On the in­vest­ment call, Ther­mo Fish­er CEO Marc Casper said that its phar­ma and biotech sec­tor had “im­pres­sive per­for­mance” with growth in the low teens for the quar­ter and mid-teens for the year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER